首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   3232027篇
  免费   247253篇
  国内免费   8164篇
耳鼻咽喉   43871篇
儿科学   104967篇
妇产科学   87710篇
基础医学   464562篇
口腔科学   89917篇
临床医学   294984篇
内科学   633662篇
皮肤病学   73687篇
神经病学   259342篇
特种医学   124712篇
外国民族医学   743篇
外科学   490802篇
综合类   70706篇
现状与发展   14篇
一般理论   1185篇
预防医学   259230篇
眼科学   73755篇
药学   236893篇
  15篇
中国医学   5996篇
肿瘤学   170691篇
  2018年   35757篇
  2017年   27430篇
  2016年   31434篇
  2015年   35104篇
  2014年   49226篇
  2013年   74717篇
  2012年   98767篇
  2011年   105603篇
  2010年   63614篇
  2009年   60458篇
  2008年   98613篇
  2007年   105192篇
  2006年   106425篇
  2005年   103129篇
  2004年   98378篇
  2003年   95170篇
  2002年   91868篇
  2001年   146839篇
  2000年   150776篇
  1999年   126940篇
  1998年   38129篇
  1997年   33595篇
  1996年   34304篇
  1995年   33312篇
  1994年   30810篇
  1993年   29003篇
  1992年   101018篇
  1991年   98587篇
  1990年   95892篇
  1989年   92080篇
  1988年   84989篇
  1987年   83434篇
  1986年   78551篇
  1985年   75593篇
  1984年   56990篇
  1983年   48393篇
  1982年   29418篇
  1981年   26472篇
  1979年   52249篇
  1978年   37602篇
  1977年   31386篇
  1976年   29717篇
  1975年   31646篇
  1974年   37765篇
  1973年   35923篇
  1972年   33770篇
  1971年   31654篇
  1970年   29017篇
  1969年   27630篇
  1968年   25460篇
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
91.
92.
Owing to the frequent incidence of blast-induced traumatic brain injury (bTBI) in recent military conflicts, there is an urgent need to develop effective therapies for bTBI-related pathologies. Blood-brain barrier (BBB) breakdown has been reported to occur after primary blast exposure, making restoration of BBB function and integrity a promising therapeutic target. We tested the hypothesis that treatment with dexamethasone (DEX) after primary blast injury potentiates recovery of an in vitro BBB model consisting of mouse brain endothelial cells (bEnd.3). DEX treatment resulted in complete recovery of transendothelial electrical resistance and hydraulic conductivity 1 day after injury, compared with 3 days for vehicle-treated injured cultures. Administration of RU486 (mifepristone) inhibited effects of DEX, confirming that barrier restoration was mediated by glucocorticoid receptor signaling. Potentiated recovery with DEX treatment was accompanied by stronger zonula occludens (ZO)-1 tight junction immunostaining and expression, suggesting that increased ZO-1 expression was a structural correlate to BBB recovery after blast. Interestingly, augmented ZO-1 protein expression was associated with specific upregulation of the α+ isoform but not the α isoform. This is the first study to provide a mechanistic basis for potentiated functional recovery of an in vitro BBB model because of glucocorticoid treatment after primary blast injury.  相似文献   
93.
94.
95.
We report on a child with several café au lait spots in association with a lumbar lipomeningomyelocele as an apparently new association. Cutaneous markers, the identification of which plays a crucial role in the early diagnosis and management of spinal malformations, can accompany occult spinal dysraphism. Herein we report a case of lumbar lipomeningomyelocele associated with an overlying café au lait spot that served as a marker of occult spinal dysraphism. The patient also had segmental café au lait spots on the face, making the association unique.  相似文献   
96.
97.
Dosage form is a mean used for the delivery of drug to a living body. In order to get the desired effect the drug should be delivered to its site of action at such rate and concentration to achieve the maximum therapeutic effect and minimum adverse effect. Since oral route is still widely accepted route but having a common drawback of difficulty in swallowing of tablets and capsules. Therefore a lot of research has been done on novel drug delivery systems. This review is about oral dispersible tablets a novel approach in drug delivery systems that are now a day''s more focused in formulation world, and laid a new path that, helped the patients to build their compliance level with the therapy, also reduced the cost and ease the administration especially in case of pediatrics and geriatrics. Quick absorption, rapid onset of action and reduction in drug loss properties are the basic advantages of this dosage form.  相似文献   
98.
Pediatric trachyonychia is an acquired nail disease that can cause distress to families. It is a poorly understood disease, and long‐term follow‐up data are lacking. We present an institutional review of 11 children with isolated pediatric trachyonychia followed over time. Children with the diagnosis of pediatric trachyonychia were identified and invited to participate. Pictures were taken on follow‐up and a questionnaire was answered. Exclusion criteria include having another diagnosis at the initial visit that causes nail dystrophy. Eleven patients with the diagnosis of pediatric trachyonychia were available for follow‐up. The mean age of appearance was 2.7 years (range 2–7 yrs) and the average follow‐up was 66 months (range 10–126 mos). Nine patients were treated with potent topical corticosteroids, one used only petrolatum, and one took vitamin supplements. One patient was found to have an additional skin and hair diagnosis of alopecia areata on follow‐up. On follow‐up, 82% noted improvement of the nails, whereas 18% noted no change. A majority of cases of pediatric trachyonychia are isolated and improve with time, regardless of treatment.  相似文献   
99.
Sinus venosus atrial septal defect (SV‐ASD) usually coexists with partial anomalous pulmonary vein connection (PAPVC). It is a difficult diagnosis in transthoracic echocardiography (TTE) due to eccentric position of defects. We present a rare case of atypical anatomical variation in PAPVC, which was never described before. Two right pulmonary veins drained into superior vena cava, which overrode SV‐ASD and interatrial septum, a third pulmonary vein into the right atrium. Complete diagnosis could not be set after TTE, nor transesophageal echocardiography, whereas angio‐CT was finally conclusive. This diagnostic approach allowed the surgical planning.  相似文献   
100.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号